Migraine affects 959 million people worldwide,1 with the highest prevalence being in women of childbearing age. The interplay between female hormones and migraine can be a challenging area to navigate since issues relating to pregnancy, contraception and the menopause are often out of the neurology comfort zone. This review aims to help the neurologist to manage women with migraine, from menarche to menopause.
Statistics from Altmetric.com
Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests SKA received speaker’s fees and participated in advisory boards for Novartis, Teva and Eli-Lilly.
Patient consent for publication Not required.
Provenance and peer review Commissioned. Externally peer reviewed by Angela O’Neal, Boston, USA, and Nicola Giffin, Bath, UK.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.